user

The who risk factor index, risk of vertebral fractures and reduction in fracture risk with alendronate: The fracture invervention trial

被引：0
|
作者：
Cummings, S. R.
Palermo, L.
Ensrud, K. E.
Schousboe, J. T.
Johansson, H.
Kanis, J. A.
机构：
[1] Univ Calif San Francisco, San Francisco Coordinating Ctr, CPMC Res Inst, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Univ Minnesota, Minneapolis, MN 55455 USA
[4] Parc Nicollet Hlth Serv, Minneapolis, MN USA
[5] WHO Collaborating Ctr Metab Bone Dis, Sheffield, S Yorkshire, England
来源：
CALCIFIED TISSUE INTERNATIONAL | 2007年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [41] The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population
    Naves, M
    Díaz-López, JB
    Gómez, C
    Rodríguez-Rebollar, A
    Rodríguez-García, M
    Cannata-Andía, JB
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 (06) : 520 - 524
  • [42] Consistency of effect of alendronate on reduction in risk of non-vertebral fractures.
    Thompson, D
    Musliner, T
    Vandormael, K
    Santora, A
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S353 - S353
  • [43] Alendronate prevents fractures in women at very high risk: Results from the fracture intervention trial.
    Ensrud, K
    Black, D
    BarrettConnor, E
    Quandt, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : 155 - 155
  • [44] VERTEBRAL FRACTURE RISK REDUCTION IS INDEPENDENT OF THE MAGNITUDE OF BMD CHANGE
    Adachi, J. D.
    Cooper, C.
    Watts, N. B.
    Manhart, M. D.
    Barton, I. P.
    Eastell, R.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S79 - S80
  • [45] Reduction in vertebral fracture risk persists after discontinuation of risedronate
    不详
    Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 (6): : 307 - 307
  • [46] Vertebral fracture risk reduction is independent of the magnitude of BMD change
    Adachi, JD
    Cooper, C
    Watts, NB
    Manhart, MD
    Barton, IP
    Eastell, R
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S53 - S54
  • [47] Risk of new vertebral fracture in the year following a fracture
    Lindsay, R
    Silverman, SL
    Cooper, C
    Hanley, DA
    Barton, I
    Broy, SB
    Licata, A
    Benhamou, L
    Geusens, P
    Flowers, K
    Stracke, H
    Seeman, E
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (03): : 320 - 323
  • [48] Risk factors for subsequent vertebral fractures following a previous hip fracture
    Sang-Min Park
    Sung Jun Go
    Heesoo Han
    Jung Wee Park
    Young-Kyun Lee
    Ho-Joong Kim
    Jin S. Yeom
    Kyung-Hoi Koo
    Journal of Bone and Mineral Metabolism, 2021, 39 : 193 - 200
  • [49] Risk factors for subsequent vertebral fractures following a previous hip fracture
    Park, Sang-Min
    Go, Sung Jun
    Han, Heesoo
    Park, Jung Wee
    Lee, Young-Kyun
    Kim, Ho-Joong
    Yeom, Jin S.
    Koo, Kyung-Hoi
    JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (02) : 193 - 200
  • [50] Unilateral primary aldosteronism as an independent risk factor for vertebral fracture
    Yokomoto-Umakoshi, Maki
    Sakamoto, Ryuichi
    Umakoshi, Hironobu
    Matsuda, Yayoi
    Nagata, Hiromi
    Fukumoto, Tazuru
    Ogata, Masatoshi
    Ogawa, Yoshihiro
    CLINICAL ENDOCRINOLOGY, 2020, 92 (03) : 206 - 213
12345